Related Experiment Video
Updated: Jun 7, 2026

Isolation and Analysis of Brain-sequestered Leukocytes from Plasmodium berghei ANKA-infected Mice
Published on: January 2, 2013
Development of experimental cerebral malaria is independent of IL-23 and IL-17
Hidekazu Ishida1, Chikako Matsuzaki-Moriya, Takashi Imai
1Department of Microbiology and Immunology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Abstract:
Cerebral malaria (CM) is the most severe complication of Plasmodium infection. Although inappropriate immune responses to Plasmodium falciparum are reported as the major causes of CM, the precise mechanisms for development remain unclear. IL-23 and IL-17 have critical roles in the onset of autoimmunity and inflammatory diseases triggered by microbial infections. Thus, we investigated the influence of IL-23 and IL-17 on experimental CM (ECM) using Plasmodium berghei ANKA infection of C57BL/6 mice. Both IL-23 deficient mice and wild-type (WT) mice developed ECM. IL-17 deficient mice also developed ECM, while IL-17 producing cells other than CD4(+) T cells (Th17) were increased in WT mice that developed ECM. In conclusion, this study showed that IL-23 and IL-17 are not involved in ECM development.
Insights
Interleukin-23 (IL-23) and Interleukin-17 (IL-17) do not appear to play a role in the development of experimental cerebral malaria (ECM). Studies in knockout and wild-type mice indicate these cytokines are not critical for ECM onset.
Area of Science:
- Immunology
- Infectious Diseases
- Neuroscience
Background:
- Cerebral malaria (CM) is a severe Plasmodium infection complication.
- Inappropriate immune responses are implicated in CM pathogenesis, but mechanisms are unclear.
- Interleukin-23 (IL-23) and Interleukin-17 (IL-17) are key in autoimmunity and inflammation.
Purpose of the Study:
- To investigate the role of IL-23 and IL-17 in experimental cerebral malaria (ECM).
Main Methods:
- Used Plasmodium berghei ANKA infection in C57BL/6 mice.
- Utilized IL-23 deficient mice and IL-17 deficient mice.
- Compared outcomes with wild-type (WT) mice.
Main Results:
- Both IL-23 deficient and WT mice developed ECM.
- IL-17 deficient mice also developed ECM.
- Increased IL-17 producing cells (non-Th17) were observed in WT mice with ECM.
Conclusions:
- IL-23 is not involved in the development of experimental cerebral malaria.
- IL-17 is not involved in the development of experimental cerebral malaria.
Related Concept Videos
Malaria
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

